3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Vomiting
1
Neoplasms
1
Nausea
1
Breast Neoplasms
1
Interventions
Dexamethasone
22
Ondansetron
20
Aprepitant
20
Palonosetron
17
Granisetron
11
Calcium Dobesilate
8
Therapeutics
7
Olanzapine
6
dexamethasone acetate
5
Doxorubicin
5
Cyclophosphamide
5
casopitant
4
Acupressure
4
netupitant
3
dolasetron
3
Yoga
3
Vincristine
3
Radiotherapy
3
Dronabinol
3
Analgesia
3
ginger extract
2
fosaprepitant
2
dexamethasone 21-phosphate
2
Tropisetron
2
Surveys and Questionnaires
2
Psychiatric Rehabilitation
2
Prochlorperazine
2
Metoclopramide
2
Mesna
2
Ifosfamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Nausea
×
alizapride
×
Clear all
NCT01636947
2018-09-25
KMEC
Merck Sharp & Dohme LLC
Phase 4
Completed
494 enrolled
14 charts